Insufficient scRNA-seq data for expression of TRGV1 at single-cell level.
Insufficient scRNA-seq data for expression of TRGV1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 93% | 10.54 | 225 / 241 | 0% | 0 | 0 / 0 |
prostate | 62% | 2.81 | 152 / 245 | 8% | 0.25 | 42 / 502 |
lung | 64% | 1.93 | 369 / 578 | 4% | 0.13 | 51 / 1155 |
stomach | 55% | 1.54 | 199 / 359 | 8% | 0.13 | 22 / 286 |
peripheral blood | 61% | 3.01 | 570 / 929 | 0% | 0 | 0 / 0 |
bladder | 48% | 1.19 | 10 / 21 | 1% | 0.05 | 6 / 504 |
thymus | 40% | 1.03 | 264 / 653 | 2% | 0.04 | 15 / 605 |
intestine | 39% | 1.26 | 379 / 966 | 2% | 0.05 | 12 / 527 |
pancreas | 37% | 0.84 | 122 / 328 | 1% | 0.01 | 2 / 178 |
adipose | 38% | 0.75 | 457 / 1204 | 0% | 0 | 0 / 0 |
breast | 29% | 0.56 | 133 / 459 | 3% | 0.06 | 32 / 1118 |
esophagus | 24% | 0.42 | 342 / 1445 | 7% | 0.11 | 12 / 183 |
uterus | 28% | 0.51 | 48 / 170 | 0% | 0.01 | 2 / 459 |
kidney | 22% | 0.45 | 20 / 89 | 4% | 0.08 | 34 / 901 |
adrenal gland | 25% | 0.40 | 64 / 258 | 0% | 0 | 0 / 230 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.50 | 7 / 29 |
skin | 18% | 0.34 | 327 / 1809 | 1% | 0.02 | 7 / 472 |
liver | 18% | 0.30 | 40 / 226 | 0% | 0.01 | 2 / 406 |
ovary | 17% | 0.25 | 30 / 180 | 1% | 0.01 | 3 / 430 |
heart | 17% | 0.29 | 143 / 861 | 0% | 0 | 0 / 0 |
brain | 16% | 0.27 | 418 / 2642 | 0% | 0.00 | 2 / 705 |
blood vessel | 15% | 0.29 | 201 / 1335 | 0% | 0 | 0 / 0 |
muscle | 6% | 0.07 | 46 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0042101 | Cellular component | T cell receptor complex |
Gene name | TRGV1 |
Protein name | Probable non-functional T cell receptor gamma variable |
Synonyms | |
Description | FUNCTION: Probable non-functional open reading frame (ORF) of V region of the variable domain of T cell receptor (TR) gamma chain . Non-functional ORF generally cannot participate in the synthesis of a productive T cell receptor (TR) chain due to altered V-(D)-J or switch recombination and/or splicing site (at mRNA level) and/or conserved amino acid change (protein level) . Gamma-delta TRs recognize a variety of self and foreign non-peptide antigens frequently expressed at the epithelial boundaries between the host and external environment, including endogenous lipids presented by MH-like protein CD1D and phosphoantigens presented by butyrophilin-like molecule BTN3A1. Upon antigen recognition induces rapid, innate-like immune responses involved in pathogen clearance and tissue repair . Binding of gamma-delta TR complex to antigen triggers phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) in the CD3 chains by the LCK and FYN kinases, allowing the recruitment, phosphorylation, and activation of ZAP70 that facilitates phosphorylation of the scaffolding proteins LCP2 and LAT. This lead to the formation of a supramolecular signalosome that recruits the phospholipase PLCG1, resulting in calcium mobilization and ERK activation, ultimately leading to T cell expansion and differentiation into effector cells . Gamma-delta TRs are produced through somatic rearrangement of a limited repertoire of variable (V), diversity (D), and joining (J) genes. The potential diversity of gamma-delta TRs is conferred by the unique ability to rearrange (D) genes in tandem and to utilize all three reading frames. The combinatorial diversity is considerably increased by the sequence exonuclease trimming and random nucleotide (N) region additions which occur during the V-(D)-J rearrangements . . |
Accessions | A0A0A0MS02 ENST00000390348.2 |